Sample size considerations for historical control studies with survival outcomes

被引:10
作者
Zhu, Hong [1 ]
Zhang, Song [1 ]
Ahn, Chul [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Div Biostat, Dept Clin Sci, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
关键词
Clinical trial; historical control; percentiles of type I error and power; sample size; survival outcome; CLINICAL-TRIALS; LUNG-CANCER; POWER; COMBINATION; COHORT;
D O I
10.1080/10543406.2015.1052495
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Historical control trials (HCTs) are frequently conducted to compare an experimental treatment with a control treatment from a previous study, when they are applicable and favored over a randomized clinical trial (RCT) due to feasibility, ethics and cost concerns. Makuch and Simon developed a sample size formula for historical control (HC) studies with binary outcomes, assuming that the observed response rate in the HC group is the true response rate. This method was extended by Dixon and Simon to specify sample size for HC studies comparing survival outcomes. For HC studies with binary and continuous outcomes, many researchers have shown that the popular Makuch and Simon method does not preserve the nominal power and type I error, and suggested alternative approaches. For HC studies with survival outcomes, we reveal through simulation that the conditional power and type I error over all the random realizations of the HC data have highly skewed distributions. Therefore, the sampling variability of the HC data needs to be appropriately accounted for in determining sample size. A flexible sample size formula that controls arbitrary percentiles, instead of means, of the conditional power and type I error, is derived. Although an explicit sample size formula with survival outcomes is not available, the computation is straightforward. Simulations demonstrate that the proposed method preserves the operational characteristics in a more realistic scenario where the true hazard rate of the HC group is unknown. A real data application of an advanced non-small cell lung cancer (NSCLC) clinical trial is presented to illustrate sample size considerations for HC studies in comparison of survival outcomes.
引用
收藏
页码:657 / 671
页数:15
相关论文
共 21 条
[1]   Incidence of malignancies in patients with diabetes mellitus and correlation with treatment modalities in a large Israeli health maintenance organization: a historical cohort study [J].
Buchs, Andreas E. ;
Silverman, Barbara G. .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2011, 60 (10) :1379-1385
[2]   RANDOMIZED CLINICAL-TRIALS - PERSPECTIVES ON SOME RECENT IDEAS [J].
BYAR, DP ;
SIMON, RM ;
FRIEDEWALD, WT ;
SCHLESSELMAN, JJ ;
DEMETS, DL ;
ELLENBERG, JH ;
GAIL, MH ;
WARE, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (02) :74-80
[3]   Mesothelioma and lung cancer mortality: A historical cohort study among asbestosis workers in Hong Kong [J].
Chen, Minghui ;
Tse, Lap Ah ;
Au, Ronald K. F. ;
Yu, Ignatius T. S. ;
Wang, Xiao-rong ;
Lao, Xiang-qian ;
Au, Joseph Siu-kei .
LUNG CANCER, 2012, 76 (02) :165-170
[4]   SAMPLE-SIZE CONSIDERATIONS FOR STUDIES COMPARING SURVIVAL CURVES USING HISTORICAL CONTROLS [J].
DIXON, DO ;
SIMON, R .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1988, 41 (12) :1209-1213
[6]   THE EVALUATION OF THERAPIES - HISTORICAL CONTROL STUDIES [J].
GEHAN, EA .
STATISTICS IN MEDICINE, 1984, 3 (04) :315-324
[8]   Adjusting power for a baseline covariate in linear models [J].
Glueck, DH ;
Muller, KE .
STATISTICS IN MEDICINE, 2003, 22 (16) :2535-2551
[9]   Using historical controls to adjust for covariates in trend tests for binary data [J].
Ibrahim, JG ;
Ryan, LM ;
Chen, MH .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1998, 93 (444) :1282-1293
[10]  
Keiding N., 1995, LIFETIME DATA ANAL, V1, P1